Thyrocare Q2 FY27 Earnings Presentation

29 October 2026, 10:55 UTC

Thyrocare Technologies Ltd reports Q2 FY27 revenue of ₹270.8 crore, up 25.1% YoY, with EBITDA margin at 33.0%.

EBITDA was ₹89.3 crore; margin expanded from 29.5% in Q2 FY26 and 32.2% in Q1 FY27.
PAT before the NHL impairment-related exception was approximately ₹60.1 crore, up 25.7% YoY.
The company opened five labs and launched a pregnancy test kit that includes a lab test.

This is an automated summary of a public document. Always check the original before relying on it.